Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Tuberculosis: the story after the Primer

Nature Reviews Disease Primers volume 6, Article number: 29 (2020) Cite this article

Subjects

Collaboration between authors and journal staff can contribute to expand the reach of Primers, including to areas where they would be most useful.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Pai, M. et al. Tuberculosis. Nat. Rev Dis Primers 2, 1–23 (2016).

    Article  Google Scholar 

  2. World Health Organization. Global Tuberculosis Report 2019. who.com https://www.who.int/tb/global-report-2019(2019).

  3. Van Der Meeren, O. et al. Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis. N. Engl. J. Med. 379, 1621–1634 (2018).

    Article  Google Scholar 

  4. US Food & Drug Administration. FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs. fda.gov https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-resistant-forms-tuberculosis-affects-lungs (2019).

  5. Swindells, S. et al. One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. N. Engl. J. Med. 380, 1001–1011 (2019).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. McGill International Tuberculosis Centre, McGill University, Montreal, Québec, Canada

    Madhukar Pai

  2. Manipal McGill Program for Infectious Diseases, Manipal Centre for Infectious Diseases, Manipal Academy of Higher Education, Manipal, India

    Madhukar Pai

Authors
  1. Madhukar Pai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Madhukar Pai.

Ethics declarations

Competing interests

The author declares no competing interests.

Additional information

Related links

Nature Microbiology Community blog: https://naturemicrobiologycommunity.nature.com/users/20892-madhukar-pai/posts/12911-first-primer-on-tuberculosis-in-nature-reviews-disease-primers

Research4Life: https://www.research4life.org/

SharedIt: https://www.springernature.com/gp/researchers/sharedit

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pai, M. Tuberculosis: the story after the Primer. Nat Rev Dis Primers 6, 29 (2020). https://doi.org/10.1038/s41572-020-0161-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41572-020-0161-5

Search

Advanced search

Quick links

Nature Briefing Microbiology

Sign up for the Nature Briefing: Microbiology newsletter — what matters in microbiology research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Microbiology